1. Balancing on-site and central monitoring: Where does new evidence leads us?
SCT/ICTMC 2017 – Invited Session

2. Setting On-site monitoring is… time-consuming resource hungry
Many interpret GCP to require much site monitoring
Academic trials = fewer site visits, industry trials = more
Many suggest to focus more on central monitoring
Many suggest that only site visits can find key problems
Limited evidence to judge central vs on-site balance
Some teams have run studies:
ADAMON, OPTIMON, TEMPER

3. Session plan Will Cragg + Sally Stenning TEMPER – first results 18 min
MRC Clinical Trials Unit at UCL, London, UK
Valerie Journot OPTIMON 18 min INSERM, Paris, France
Dirk Hasenclever ADAMON – first results 18 min
IMISE, University of Leipzig, Germany
Anne Lindblad Discussion 15 min
Emmes Corporation, USA
Panel discussion With audience questions To end